Development Level

Tbio 25 | 11,178
Tchem 15 | 1,885
Tclin 7 | 612
Tdark 2 | 6,569

Collection

GPCR: IDG Consortium (Targets) 2 | 126
Kinase: IDG Consortium (Target... 2 | 125

IMPC Phenotype

preweaning lethality, complete... 4 | 979
abnormal seminal vesicle morph... 2 | 114
decreased circulating creatini... 2 | 39
decreased lymphocyte cell numb... 2 | 83
enlarged heart 2 | 210
increased monocyte cell number 2 | 63
preweaning lethality, incomple... 2 | 499
abnormal coat appearance 1 | 31
abnormal colon morphology 1 | 3
abnormal gait 1 | 69
abnormal heart morphology 1 | 162
abnormal ileum morphology 1 | 2
abnormal kidney morphology 1 | 65
abnormal testis morphology 1 | 43
decreased circulating insulin ... 1 | 76
decreased heart rate 1 | 18
decreased prepulse inhibition 1 | 82
decreased total body fat amoun... 1 | 207
decreased vertical activity 1 | 208
embryonic lethality prior to o... 1 | 239
embryonic lethality prior to t... 1 | 278
enlarged uterus 1 | 11
hydrometra 1 | 53
increased circulating HDL chol... 1 | 80
increased circulating alkaline... 1 | 122
increased circulating choleste... 1 | 66
increased circulating phosphat... 1 | 26
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 96
increased mean corpuscular hem... 1 | 36
increased neutrophil cell numb... 1 | 46
male infertility 1 | 123
polycystic kidney 1 | 15
prolonged RR interval 1 | 8
small superior vagus ganglion 1 | 74
small testis 1 | 58
thrombocytopenia 1 | 56

Disease

Carcinoma 31 | 11,192
osteosarcoma 27 | 7,766
ovarian cancer 27 | 8,297
Cancer 25 | 2,388
lung cancer 25 | 4,607
medulloblastoma, large-cell 25 | 6,086
psoriasis 25 | 6,514
non-small cell lung cancer 22 | 2,799
lung carcinoma 21 | 2,755
malignant mesothelioma 21 | 3,135
glioblastoma 20 | 5,635
invasive ductal carcinoma 19 | 2,867
Breast cancer 17 | 3,469
interstitial cystitis 17 | 2,237
ependymoma 16 | 4,559
lung adenocarcinoma 16 | 2,627
ulcerative colitis 16 | 1,765
atypical teratoid / rhabdoid tumor 15 | 4,971
intraductal papillary-mucinous carcinoma (IPMC) 15 | 2,902
intraductal papillary-mucinous adenoma (IPMA) 14 | 2,872
cutaneous lupus erythematosus 13 | 1,016
subependymal giant cell astrocytoma 13 | 2,230
intraductal papillary-mucinous neoplasm (IPMN) 12 | 3,204
adrenocortical carcinoma 11 | 1,385
breast carcinoma 11 | 1,589
cystic fibrosis 11 | 1,629
group 3 medulloblastoma 11 | 4,002
pancreatic cancer 11 | 2,322
Astrocytoma, Pilocytic 10 | 3,006
adult high grade glioma 10 | 3,701
oligodendroglioma 10 | 2,768
colon cancer 9 | 1,428
primitive neuroectodermal tumor 9 | 2,957
Breast Neoplasms 8 | 423
Kidney cancer 8 | 2,548
astrocytic glioma 8 | 2,530
gastric carcinoma 8 | 781
mucosa-associated lymphoid tissue lymphoma 8 | 473
pancreatic ductal adenocarcinoma liver metastasis 8 | 1,911
pituitary cancer 8 | 1,915
primary Sjogren syndrome 8 | 710
tuberculosis 8 | 1,963
Liver Cirrhosis, Experimental 7 | 733
Rheumatoid arthritis 7 | 1,156
Schizophrenia 7 | 1,136
group 4 medulloblastoma 7 | 1,806
Carcinoma, Hepatocellular 6 | 217
Duchenne muscular dystrophy 6 | 587
Liver carcinoma 6 | 229
Mammary Neoplasms 6 | 403
astrocytoma 6 | 1,113
autosomal dominant Emery-Dreifuss muscular dystrophy 6 | 492
ductal carcinoma in situ 6 | 1,686
nasopharyngeal carcinoma 6 | 1,024
Asthma 5 | 370
Atopic dermatitis 5 | 915
Constipation 5 | 174
Endometriosis 5 | 521
Hypertension 5 | 372
Multiple Sclerosis 5 | 527
Neoplasm Metastasis 5 | 160
Pulmonary Fibrosis 5 | 101
Seizures 5 | 584
pediatric high grade glioma 5 | 1,035
primary pancreatic ductal adenocarcinoma 5 | 1,071
urothelial carcinoma 5 | 303
Atherosclerosis 4 | 276
Autosomal recessive predisposition 4 | 1,407
Blastic phase chronic myeloid leukemia 4 | 58
Chronic Myelocytic Leukemia Accelerated Phase 4 | 59
Chronic phase chronic myeloid leukemia 4 | 45
Depressive disorder 4 | 401
Epilepsy 4 | 775
Hepatomegaly 4 | 280
Hypereosinophilic syndrome 4 | 70
Hypertensive disease 4 | 278
Kidney disease 4 | 411
Liver cancer 4 | 589
Multiple, subcutaneous nodules 4 | 49
Nausea and vomiting 4 | 93
Neoplasm Invasiveness 4 | 151
Obesity 4 | 655
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 4 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 4 | 47
Pick disease 4 | 1,856
Prostatic Neoplasms 4 | 472
Renal Cell Carcinoma 4 | 211
Small head 4 | 366
Stomach Neoplasms 4 | 287
Subcutaneous nodule 4 | 49
Vascular disease 4 | 294
Waldenstrons macroglobulinemia 4 | 742
active Crohn's disease 4 | 882
active ulcerative colitis 4 | 736
aldosterone-producing adenoma 4 | 646
diabetes mellitus 4 | 1,683
hepatocellular carcinoma 4 | 536
medulloblastoma 4 | 702
esophageal adenocarcinoma 3 | 696
spina bifida 3 | 1,053

Tissue

Blood and immune system 47 | 16,909
Digestive Tract 47 | 17,369
Endocrine System 47 | 18,159
Female tissues 47 | 17,400
Nervous System 46 | 16,725
Skin and soft tissues 46 | 17,230
Urinary Tract 46 | 16,678
Liver and Pancreas 45 | 16,750
Male tissues 45 | 17,142
Respiratory system 45 | 16,393
Cardiovascular System 41 | 15,192

Target Family

Non-IDG 21 | 12,091
GPCR 11 | 408
Kinase 10 | 634
Enzyme 3 | 4,145
Transcription Factor 3 | 1,400
Transporter 1 | 473

GO Process

cell chemotaxis 49 | 49
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Homeobox protein Hox-B9 HOXB9 Tbio Transcription Factor -1.81434 33.6 255
Probable G-protein coupled receptor 33 GPR33 Tdark GPCR 0.00000 2
Ephrin type-A receptor 2 EPHA2 Tclin Kinase -2.91920 874.6 873
C-C motif chemokine 20 CCL20 Tbio Non-IDG -3.10283 1250.3 496
Semaphorin-5A SEMA5A Tbio Non-IDG -1.82162 69.8 238
Ephrin type-B receptor 1 EPHB1 Tchem Kinase -1.70013 52.0 389
N-formyl peptide receptor 3 FPR3 Tbio GPCR -1.41613 24.4 247
Endoglin ENG Tbio Non-IDG -3.10482 1235.9 1622
Stromal cell-derived factor 1 CXCL12 Tbio Non-IDG -3.48446 3085.9 607
High mobility group protein B2 HMGB2 Tbio Transcription Factor -1.52510 34.5 267